Quest Diagnostics share price and momentum signal (NYSE: DGX)

NYSE · Health Care · Data to 4 Nov 2026

Current signal

High Signal

5-day average model probability 82.0% · in this band for 94 trading days

Adjusted close $255.68 4 Nov 2026

The probability is the model's estimate that the closing price 34 calendar days later will be above its 150-day exponential moving average. High is 52.5% and above, Moderate from 50.5%. How the signal works.

Price and model probability, last 12 months

Quest Diagnostics: daily adjusted close and model probability since 4 Nov 202552.5%50.5%0%Model probability (daily)$255.68$173.49Nov 2025Apr 2026Nov 2026
Last 10 trading days as a table
DateAdjusted closeModel probability
4 Nov 2026$255.6882.4%
3 Nov 2026$247.0679.9%
2 Nov 2026$250.8181.7%
30 Oct 2026$251.8282.1%
29 Oct 2026$252.9284.0%
28 Oct 2026$245.6281.4%
27 Oct 2026$242.5679.7%
26 Oct 2026$242.9580.7%
23 Oct 2026$241.8982.0%
22 Oct 2026$243.2881.3%

Key figures

1 month
+10.5%
3 months
+8.4%
6 months
+35.2%
12-month high
$255.68 4 Nov 2026
12-month low
$173.49 5 Jan 2026
From the high
+0.0%

Changes are in adjusted closing price to 4 Nov 2026; the 12-month range covers trading since 4 Nov 2025.

Research on Quest Diagnostics

No research notes on Quest Diagnostics yet.

Other Health Care stocks

All Health Care stocks

Questions about Quest Diagnostics

What is the current PredictivePick momentum signal for Quest Diagnostics?

As of 4 Nov 2026, Quest Diagnostics (DGX) has a High Signal. Its model probability, averaged over the last 5 trading days, is 82.0%. The signal is High at 52.5% and above, Moderate from 50.5%, and Low below that.

How has the Quest Diagnostics share price moved recently?

Based on adjusted closing prices to 4 Nov 2026, Quest Diagnostics has changed +10.5% over one month, +8.4% over three months and +35.2% over six months. Since 4 Nov 2025 it has traded between $173.49 and $255.68.

Which sector is Quest Diagnostics in?

Quest Diagnostics is classified under Health Care. Other Health Care stocks PredictivePick covers include ResMed, Revvity, Steris, Stryker, UnitedHealth Group, Universal Health Services, Abbott Laboratories, Amgen.

What does the PredictivePick signal for Quest Diagnostics measure?

It is the model's estimated probability that the stock's closing price 34 calendar days later will be above its 150-day exponential moving average. It is a statistical estimate, not a price target or a recommendation. Signals are model estimates calculated from publicly available market data. They are not investment advice, do not represent actual trading results, and are not claimed to be accurate or complete.

Signals are model estimates calculated from publicly available market data. They are not investment advice, do not represent actual trading results, and are not claimed to be accurate or complete. See the full disclaimer.

Join our Telegram